NCT05786924 2026-04-21Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive MalignanciesServierPhase 1/2 Recruiting554 enrolled
NCT03093116 2026-04-03TRIDENT-1Turning Point Therapeutics, Inc.Phase 1/2 Recruiting500 enrolled 4 FDA
NCT07433283 2026-02-25Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid TumorSichuan Enray Pharmaceutical Sciences CompanyPhase 1/2 Recruiting54 enrolled
NCT07023731 2026-02-19A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D MutationArvinas Inc.Phase 1/2 Recruiting159 enrolled
NCT06239194 2025-06-22Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid TumorsModeX Therapeutics, An OPKO Health CompanyPhase 1/2 Recruiting115 enrolled